Dermatol. praxi. 2017;11(2):83-85 | DOI: 10.36290/der.2017.039

Paracetamol induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome

MUDr. Tereza Chrpová Maulenová
Kožní oddělení, Masarykova nemocnice v Ústí nad Labem

Stevens–Johnson syndrome and toxic epidermal necrolysis are severe and potentially life-threatening skin conditions caused most

frequently by a hypersensitive reaction to medication. Paracetamol, which is the most frequently used pharmaceutical mean for

fever and aches, appeared to be a relatively safe medication in a clinical practice. However, there have been several cases of severe

post-medical reactions described in the literature. In this article, we present a case report of a patient with Stevens–Johnson

syndrome and toxic epidermal necrolysis overlap syndrome following paracetamol use.

Keywords: Stevens-Johnson syndrome, toxic epidermal necrolysis, overlap syndrom, paracetamol

Received: May 14, 2017; Accepted: May 27, 2017; Published: June 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chrpová Maulenová T. Paracetamol induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome. Dermatol. praxi. 2017;11(2):83-85. doi: 10.36290/der.2017.039.
Download citation

References

  1. Odarčenková D, Kvapil M. Toxická epidermální nekrolýza. Vnitřní lékařství, 2016; 62(1): 62-69. ISSN: 0042-773X.
  2. Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis - Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol 2013; 69(2): 173.e1-173.e13. Go to original source... Go to PubMed...
  3. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: Our current understanding. Allergol Int. 2006; 55(1): 9-16. Go to original source... Go to PubMed...
  4. Lyell A. Toxic epidermal necrolysis: an eruption resembeling scalding of the skin. Br J Dermatol 1956; 68: 355-361. Go to original source... Go to PubMed...
  5. Lipový B. A potential new sign in patients with toxic epidermal necrolysis. Burns. 2016, 42(7): 1618-1620. DOI: 10.1016/j.burns.2016.07.014. Go to original source... Go to PubMed...
  6. Deore SS, Dandekar RC, Mahajan AM, Shiledar VV. Drug induced-Stevens Johnson syndrome: A case report. Int J Sci Stud. 2014; 2(4): 84-87. Dostupné také z: http://www.ijss-sn.com/uploads/2/0/1/5/20153321/ijss_july-17.pdf
  7. Slim R, Fathallah N, Aounallah A, Ksiaa M, Sriha B, Nouira R, Salem Ch B. Paracetamol-Induced Stevens Jonhson Syndrome nad Cholestatic Hepatitis. Current Drug Safety. 2015; 10(2): 187-189. Go to original source... Go to PubMed...
  8. Salavec M. Epidermální nekrolýza (Stevensův-Johnsonův syndrom a toxická epidermální nekrolýza. Česká dermatovenerologie. 2016; 6(2): 75-83.
  9. Biswal, S, Sahoo SS. Paracetamol induced Stevens-Johnson sydrome - toxic epidermal necrolysis overlap syndrome. International Journal of Dermatology. 2014; 53(8): 1042-1044. doi: 10.1111/ijd.12355. Go to original source... Go to PubMed...
  10. Čábalová L, Zeleník K, Komínek P. Stevensův-Johnsonův syndrom - kazuistika. Klinická mikrobiologie a infekční lékařství. 2013; 19(4): 115-119. ISSN 1211-264X. Go to PubMed...
  11. Dhaifullah A, León Ponce MF, Dřízhal I, Žák P. Toxická epidermální nekrolýza. Kazuistika. Lékařské zprávy Lékařské fakulty Univerzity Karlovy v Hradci Králové. 2004; 49(3-4): 107-112.
  12. Lipový B. Současné poznatky imunogenetiky ve vztahu k rozvoji závažných polékových kožních reakcí. Dermatologie pro praxi. 2015; 9(3): 124-127. ISSN 1802-2960.
  13. Lipový B, Gregorová N, Fiamoli M. Polékové dermatologické katastrofy v ambulantní praxi. Referátový výběr z dermatovenerologie. 2011; 53(4): 35-40. ISSN 1213-9106.
  14. Rajput R, Sagari S, Durgavanshi A, Kanwar A. Paracetamol induced Steven: A rare case report. Contemp Clin Dent. 2015; 6(1): 278-281. DOI: 10.4103/0976-237X.166838. ISBN 10.4103/0976. Dostupné také z: http://www.contempclindent.org/text.asp?2015/6/6/278/166838. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.